Vyvanse 30 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F8ACJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,967
Award facts
- Contract value 100% obligated
- $34,966.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $34,966.89 delivery order to AmerisourceBergen Drug Corp on February 20, 2026, for Vyvanse 30 mg capsule 100-count units, with a ceiling value of $34,966.89 and ultimate completion date of February 23, 2026.
Place of performance is Conshohocken, PA. The order carries firm fixed pricing and was issued under no set-aside.
Quick answers
Who was awarded contract SPE2DR26F8ACJ?
SPE2DR26F8ACJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 20, 2026.
How much is contract SPE2DR26F8ACJ worth?
The government has obligated $34,967 on SPE2DR26F8ACJ.
Is contract SPE2DR26F8ACJ an order under another contract?
Yes. SPE2DR26F8ACJ is a delivery order under SPE2DR25D7066, an indefinite delivery contract.
Was contract SPE2DR26F8ACJ competed?
The extent of competition for SPE2DR26F8ACJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award